To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Association of PTHrP leve… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Association of PTHrP levels in CSF with Alzheimer's disease biomarkers

Journal article
Authors M. M. Kushnir
Wojciech Michno
A. L. Rockwood
Kaj Blennow
F. G. Strathmann
Jörg Hanrieder
Published in Clinical Mass Spectrometry
Volume 14
Pages 124-129
ISSN 2376-9998
Publication year 2019
Published at Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Pages 124-129
Language en
Keywords Alzheimer's disease, Parathyroid hormone-related protein, PTHrP, Mass, spectrometry, Tau protein, Phosphorylated tau protein, Beta-amyloid, hormone-related protein, immunoreactive parathyroid-hormone, cerebrospinal-fluid, mass-spectrometry, lc-ms/ms, receptor, peptide, brain, quantification, thyroglobulin
Subject categories Neurochemistry


Background: Parathyroid hormone-related protein (PTHrP) is involved in intracellular calcium regulation, neural cell proliferation and synaptic transmission. To date, no studies have been performed to evaluate the potential of PTHrP concentrations in cerebrospinal fluid (CSF) as a biomarker of brain pathophysiology. In this study we evaluated the association between CSF concentrations of PTHrP with the core CSF biomarkers of Alzheimer's disease (AD). Methods: PTHrP and calcium were analysed using validated mass spectrometry based methods in a set of CSF samples that tested positive (n=45) and negative (n=45) for the AD biomarkers, including total tau protein (T-tau), phosphorylated tau protein (P-tau) and amyloid-beta 42 (A beta 42). The measured CSF concentrations of PTHrP and calcium (Ca) were evaluated for association with AD CSF biomarkers. Results: PTHrP and Ca concentrations in CSF samples ranged between 25 and 137 pmol/L and 0.92-1.53 mmol/L, respectively. Higher concentrations of PTHrP were observed in association with increased concentrations of T-tau and P-tau in the AD and the control group; while a stronger correlation was observed in the control group (rho=0.6, p < 0.0001; and rho=0.72, p < 0.0001, for T-tau and P-tau, respectively). Negative correlation was observed between concentrations of PTHrP and A beta 42 in the AD group (rho=0.27, p=0.015). A statistically significantly lower ratio A beta 42/PTHrP was observed in the AD group (p < 0.0001). Conclusion: In the current study, we observed an association of PTHrP concentrations with concentrations of clinically used CSF biomarkers of AD. Concentrations of PTHrP were positively correlated with concentrations of T-tau and P-tau, suggesting an association with neuronal secretion and function, which is reduced upon progression to AD pathology. Our data suggest potential utility of the A beta 42/PTHrP ratio in assessment of AD progression.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?